Latest Capital Raise News

Orpheus Uranium Limited reported a net cash outflow from operations and investing in the June quarter but strengthened its cash position through financing activities, extending its funding runway to over seven quarters.

DMC Mining’s planned acquisition of the Firawa and Labé uranium projects in Guinea faces delays due to exploration license approvals, while the company’s cash reserves dwindle to just A$14,000.

betr Entertainment has increased its all-scrip takeover bid for PointsBet shares to an equivalent of $1.35 per share, outbidding MIXI's $1.20 cash offer and positioning itself as the preferred suitor.

DMC Mining Group reported a modest cash outflow for Q2 2025 while securing a loan facility variation and launching a $6 million capital raising to bolster its funding position.

European Lithium Limited reported strong Q2 2025 progress with significant share sales in Critical Metals Corp raising over A$12.8 million, alongside promising exploration and development updates across Greenland, Austria, Ireland, and Australia.

Talga Group has cemented its position in the European battery materials sector by securing full mining rights for its Nunasvaara South graphite mine and signing a binding supply agreement with fast-charging battery pioneer Nyobolt.

Renegade Exploration has acquired four promising projects in Nevada's Walker Lane trend, revealing impressive high-grade gold and silver samples, while advancing its Yukon and Australian assets amid a recent $1.8 million capital raise.

Opyl Limited has secured three key partnerships validating its AI-driven TrialKey platform, completed a strategic review to boost AI capabilities, and strengthened its balance sheet with a $1.5 million capital raise and Bitcoin investment.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.

Citigold Corporation Limited reports steady progress in exploration and mine design at its Charters Towers Gold Project, while actively pursuing funding partnerships to restart operations.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.